Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-M08D1 in Advanced Digestive Tract and Solid Tumors
NCT07780318Phase 2Recruiting
- Sponsor
- Biokin Pharmaceutical
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of BL-M08D1 in gastrointestinal tumor, solid tumor, sponsored by Biokin Pharmaceutical. Started Sep 2026; status: recruiting.
02
Drugs
BL-M08D1
03
Conditions
gastrointestinal tumorsolid tumor
Beyond the preview
Go deeper on NCT07780318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07780318.